Department of Pharmacy , University of Salerno , via Giovanni Paolo II 132 , 84084 Fisciano , Italy.
J Chem Inf Model. 2019 Nov 25;59(11):4678-4690. doi: 10.1021/acs.jcim.9b00428. Epub 2019 Nov 1.
Structure-based virtual screening is highly used in the early stages of drug discovery to identify new putative lead compounds for a given target. However, when a small molecule elicits a biological effect, but its target is unknown, or the side effects it causes arise from its undesired interaction with unknown counterparts, the identification of its interacting targets represents an indispensable task. The computational procedure named inverse virtual screening, which relies on docking a molecule (or a small set of compounds) against panels of target proteins to select the most promising complexes, could be useful to overcome these issues. Panels can contain thousands of proteins, and they must be correctly prepared to assure the best docking performance. Therefore, the preparation of panels of proteins collected in the Protein Data Bank ( www.rcsb.org ), if manually performed, may be costly in terms of time and efforts, and this can limit the applicability of this approach in high-throughput virtual screening workflows. We here show an automated workflow to speed up panel preparation and development, and to test its performance, this protocol was initially applied to a panel of 628 viral proteins and, afterward, to a panel of transferase proteins (2789 entries) to perform a large inverse virtual screening study, testing a small set of compounds synthesized in our laboratory. Tankyrase 2 (PARP 5b) was selected as their preferred target of interaction, and the predicted binding was validated by means of surface plasmon resonance experiments. This protocol is useful for the rapid identification of the interacting target for a bioactive compound; accordingly, it facilitates the re-evaluation of the pharmacological activity of known active compounds, addressing the repurposing and the polypharmacology concepts.
基于结构的虚拟筛选在药物发现的早期阶段被广泛应用,用于鉴定针对特定靶标的新潜在先导化合物。然而,当一种小分子产生生物学效应,但它的靶标未知,或者它引起的副作用是由于其与未知对应物的不良相互作用引起的,那么鉴定其相互作用的靶标就成为一项不可或缺的任务。一种名为反向虚拟筛选的计算程序,依赖于将分子(或一小组化合物)对接靶蛋白面板,以选择最有前途的复合物,可能有助于克服这些问题。面板可以包含数千种蛋白质,并且必须正确准备以确保最佳对接性能。因此,如果手动准备从蛋白质数据库(www.rcsb.org)中收集的蛋白质面板,可能会在时间和精力方面成本高昂,这可能会限制这种方法在高通量虚拟筛选工作流程中的适用性。我们在这里展示了一种自动化工作流程,可以加快面板准备和开发的速度,并测试其性能。该方案最初应用于 628 种病毒蛋白面板,然后应用于 2789 种转移酶蛋白面板,进行大规模反向虚拟筛选研究,测试了我们实验室合成的一小部分化合物。端锚聚合酶 2(PARP5b)被选为它们首选的相互作用靶标,并通过表面等离子体共振实验验证了预测的结合。该方案可用于快速鉴定生物活性化合物的相互作用靶标;因此,它有助于重新评估已知活性化合物的药理活性,解决再利用和多药理学的概念。